Deal Making

Featured on Deal Making

Appia partners with Kite to develop cell therapies for blood and bone cancers
Deal-Making
Appia partners with Kite to develop cell therapies for blood and bone cancersAppia partners with Kite to develop cell therapies for blood and bone cancers

Kite will develop CAR-iNKT cells for the treatment of haematological malignancies using Appia Bio’s ACUA technology platform.

byMillie Nelson, Editor
Aug 10, 2021
|
2 Min Read
Advanced Instruments buying cell line dev tech firm Solentim
Upstream & Downstream Processing
Advanced Instruments buying cell line dev tech firm SolentimAdvanced Instruments buying cell line dev tech firm Solentim
byBPI Staff
Aug 9, 2021
1 Min Read
Thermo: Cell & gene therapy key to further growth in 2021
Upstream & Downstream Processing
Thermo: Cell & gene therapy key to further growth in 2021Thermo: Cell & gene therapy key to further growth in 2021
byGareth Macdonald
Aug 5, 2021
3 Min Read
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
Deal-Making
Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’Bayer buys Vividion for $1.5bn in ‘arm’s length acquisition’
byMillie Nelson
Aug 5, 2021
2 Min Read
Sanofi bolsters mRNA capabilities with Translate buy
Deal-Making
Sanofi bolsters mRNA capabilities with Translate buySanofi bolsters mRNA capabilities with Translate buy
byMillie Nelson
Aug 3, 2021
2 Min Read
Sartorius buys media firm Xell among ‘lively’ M&A environment
Upstream & Downstream Processing
Sartorius buys media firm Xell among ‘lively’ M&A environmentSartorius buys media firm Xell among ‘lively’ M&A environment
byDan Stanton
Jul 30, 2021
2 Min Read

More from Deal Making

Resilience forks out $110m for Bluebird site in cell therapy partnership
Deal-Making
Resilience forks out $110m for Bluebird site in cell therapy partnership
Resilience forks out $110m for Bluebird site in cell therapy partnership
Jul 30, 2021
|
2 Min Read
byMillie Nelson, Editor
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Deal-Making
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Belgian Biotechs unite to manufacture llama-based COVID antibodies
Jul 28, 2021
|
2 Min Read
byMillie Nelson, Editor
PerkinElmer continues M&A path with $5.25bn BioLegend deal
Deal-Making
PerkinElmer continues M&A path with $5.25bn BioLegend deal
PerkinElmer continues M&A path with $5.25bn BioLegend deal
Jul 27, 2021
|
2 Min Read
byDan Stanton, Editorial director
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Deal-Making
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Samsung Biologics to manufacture Kineta’s antibody immunotherapy
Jul 26, 2021
|
2 Min Read
byMillie Nelson, Editor
Second Bluebird gene therapy approval a boon for Minaris
Therapeutic Class
Second Bluebird gene therapy approval a boon for Minaris
Second Bluebird gene therapy approval a boon for Minaris
Jul 22, 2021
|
2 Min Read
byDan Stanton, Editorial director
BioNTech adds Kite’s T cell platform and production facility
Deal-Making
BioNTech adds Kite’s T cell platform and production facility
BioNTech adds Kite’s T cell platform and production facility
Jul 21, 2021
|
2 Min Read
byMillie Nelson, Editor
Forge Bio wins GentiBio AAV vector contract
Facilities & Capacity
Forge Bio wins GentiBio AAV vector contract
Forge Bio wins GentiBio AAV vector contract
Jul 16, 2021
|
2 Min Read
byDan Stanton, Editorial director
Rebranded AMRI on spending spree with LakePharma and Integrity buys
Deal-Making
Rebranded AMRI on spending spree with LakePharma and Integrity buys
Rebranded AMRI on spending spree with LakePharma and Integrity buys
Jul 15, 2021
|
3 Min Read
byDan Stanton, Editorial director
Poseida joins Cellares’ early-access cell therapy tech program
Deal-Making
Poseida joins Cellares’ early-access cell therapy tech program
Poseida joins Cellares’ early-access cell therapy tech program
Jul 14, 2021
|
3 Min Read
byDan Stanton, Editorial director
Selexis and KBI to advance Immatics program towards IND
Deal-Making
Selexis and KBI to advance Immatics program towards IND
Selexis and KBI to advance Immatics program towards IND
Jul 13, 2021
|
2 Min Read
byMillie Nelson, Editor
Batavia collaborates with Swiss start-up to deliver COVID-19 vaccine
Deal-Making
Batavia collaborates with Swiss start-up to deliver COVID-19 vaccine
Batavia collaborates with Swiss start-up to deliver COVID-19 vaccine
Jul 7, 2021
|
2 Min Read
byMillie Nelson, Editor
Cytiva doubles liquid cell culture media capacity with Intermountain bolt-on
Upstream & Downstream Processing
Cytiva doubles liquid cell culture media capacity with Intermountain bolt-on
Cytiva doubles liquid cell culture media capacity with Intermountain bolt-on
Jul 2, 2021
|
1 Min Read
byDan Stanton, Editorial director
Ins & Outs: CureVac exec shake up following low COVID-19 vaccine efficacy
Deal-Making
Ins & Outs: CureVac exec shake up following low COVID-19 vaccine efficacy
Ins & Outs: CureVac exec shake up following low COVID-19 vaccine efficacy
Jul 1, 2021
|
2 Min Read
byMillie Nelson, Editor
Quantoom and eTheRNA to build RNA production system
Deal-Making
Quantoom and eTheRNA to build RNA production system
Quantoom and eTheRNA to build RNA production system
Jun 29, 2021
|
2 Min Read
byMillie Nelson, Editor
Catalent bolsters CGT biz with RheinCell Therapeutics buy
Deal-Making
Catalent bolsters CGT biz with RheinCell Therapeutics buy
Catalent bolsters CGT biz with RheinCell Therapeutics buy
Jun 25, 2021
|
2 Min Read
byMillie Nelson, Editor
Inceptor Bio creates consortium to take on cancer
Deal-Making
Inceptor Bio creates consortium to take on cancer
Inceptor Bio creates consortium to take on cancer
Jun 24, 2021
|
2 Min Read
byMillie Nelson, Editor
Lonza bags three deals in one week
Deal-Making
Lonza bags three deals in one week
Lonza bags three deals in one week
Jun 24, 2021
|
3 Min Read
byMillie Nelson, Editor
AM-Pharma expands KBI partnership for kidney disease candidate
Deal-Making
AM-Pharma expands KBI partnership for kidney disease candidate
AM-Pharma expands KBI partnership for kidney disease candidate
Jun 23, 2021
|
1 Min Read
byMillie Nelson, Editor
Repligen buys French filtration firm Polymem
Upstream & Downstream Processing
Repligen buys French filtration firm Polymem
Repligen buys French filtration firm Polymem
Jun 23, 2021
|
2 Min Read
byDan Stanton, Editorial director
ViiV to get under the skin of HIV through $40m Halozyme deal
Bioprocess Insider
ViiV to get under the skin of HIV through $40m Halozyme deal
ViiV to get under the skin of HIV through $40m Halozyme deal
Jun 23, 2021
|
2 Min Read
byDan Stanton, Editorial director
Evonik and Stanford collaborate to go beyond the capabilities of LNPs
Deal-Making
Evonik and Stanford collaborate to go beyond the capabilities of LNPs
Evonik and Stanford collaborate to go beyond the capabilities of LNPs
Jun 22, 2021
|
2 Min Read
byMillie Nelson, Editor
Eisai and BMS in $650m solid tumor ADC pact
Deal-Making
Eisai and BMS in $650m solid tumor ADC pact
Eisai and BMS in $650m solid tumor ADC pact
Jun 21, 2021
|
2 Min Read
byGareth Macdonald
Danaher entering pureplay CDMO space in $9.6bn Aldevron buy
Deal-Making
Danaher entering pureplay CDMO space in $9.6bn Aldevron buy
Danaher entering pureplay CDMO space in $9.6bn Aldevron buy
Jun 18, 2021
|
2 Min Read
byDan Stanton, Editorial director
GSK pays iTeos $625m for anti-TIGIT mAb
Deal-Making
GSK pays iTeos $625m for anti-TIGIT mAb
GSK pays iTeos $625m for anti-TIGIT mAb
Jun 16, 2021
|
2 Min Read
byMillie Nelson, Editor
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Deal-Making
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Avalon to buy China’s Senlang for cell therapy pipeline and manufacturing plant
Jun 16, 2021
|
2 Min Read
byGareth Macdonald
Ins & outs: BIO adds board members, and new CEO for Astrea
Deal-Making
Ins & outs: BIO adds board members, and new CEO for Astrea
Ins & outs: BIO adds board members, and new CEO for Astrea
Jun 15, 2021
|
2 Min Read
byMillie Nelson, Editor
Finnish CDMO Biovian to make oncolytic virus candidate for Lokon
Facilities & Capacity
Finnish CDMO Biovian to make oncolytic virus candidate for Lokon
Finnish CDMO Biovian to make oncolytic virus candidate for Lokon
Jun 15, 2021
|
2 Min Read
byDan Stanton, Editorial director
GenScript to distribute Calidi’s ‘trojan horse’ cell therapy tech
Deal-Making
GenScript to distribute Calidi’s ‘trojan horse’ cell therapy tech
GenScript to distribute Calidi’s ‘trojan horse’ cell therapy tech
Jun 14, 2021
|
2 Min Read
byMillie Nelson, Editor
Big Pharma collaborative trend to continue beyond COVID
Deal-Making
Big Pharma collaborative trend to continue beyond COVID
Big Pharma collaborative trend to continue beyond COVID
Jun 11, 2021
|
4 Min Read
byDan Stanton, Editorial director
Ins & outs: CureVac names new chief development officer
Deal-Making
Ins & outs: CureVac names new chief development officer
Ins & outs: CureVac names new chief development officer
Jun 8, 2021
|
3 Min Read
byMillie Nelson, Editor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe